Contribution of fasting and postprandial hyperglycemia to hemoglobin A 1c in insulin-treated Japanese diabetic patients

Endocrine Journal

Volumn 55, Issue 4, 2008, Pages 753-756

  Shimizu, Hiroyuki ^a   Uehara, Yutaka ^a   Okada, Shuichi ^a   Mori, Masatomo ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Diabetes mellitus; Hemoglobin A1c; Insulin; Postprandial hyperglycemia

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; DIET RESTRICTION; GLUCOSE BLOOD LEVEL; HOME MONITORING; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; JAPAN; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE; SELF MONITORING; TEST MEAL;

DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; INSULIN; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD;

EID: 51449095967     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K07E-142     Document Type: Article

References (8)

1. Turner R, Cull C, Holman R (1996) United Kingdom Prospective Diabetes Study 17. A 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus. Ann Intern Med 124: 136-145.
2. 1c with cardiovascular disease and mortality in adults: The European prospective investigation into cancer in Norfolk. Ann Intern Med 141: 413-420.
3. American Diabetes Association (2001) Postprandial blood glucose (Consensus Statement) Diabetes Care 24: 775-778.
4. 1c and indices of glucose tolerance derived from a standardized meal test in newly diagnosed treatment naïve subjects with Type 2 diabetes. Diabet Med 23: 990-995.
5. 1c. Diabetes Care 26: 881-885.
6. Monnier L, Colette C, Monnier L, Colette C (2006) Contributions of fasting and postrandial glucose to hemoglobin A1c. Endocr Pract 12 (Suppl 1): 42-46.
7. Raskin P, Allen E, Hollander P, Lewin A, Gabbay RA, Hu P, Bode B, Garber A, for the INITIATE Study Group (2005) Initiating insulin therapy in type 2 diabetes. Diabetes Care 28: 260-265.
8. Kann PH, Wascher T, Zackova V, Moeller J, Medding J, Szocs A, Mokan M, Mrevlje F, Regulski M (2006) Starting insulin therapy in type 2 diabetes: Twice-daily biphasic insulin Aspart 30 plus metformin versus once-daily insulin glargine plus glimepiride. Exp Clin Endocrinol Diabetes 114: 527-532.